Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2018OncoTargets and TherapyOpen Access

Peripheral inflammation/immune indicators of chemosensitivity and prognosis in breast cancer patients treated with neoadjuvant chemotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

YQYi QianJTJing TaoXLXiu‐Qing Li

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Qian et al. (2018) studied this question.

synapsesocial.com/papers/6a8bca4bc716e89f35defabbhttps://doi.org/10.2147/ott.s148496
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Baseline Ratio of Neutrophils to Lymphocytes Is Associated with Patient Prognosis in Advanced Gastric Cancer2007 · 465 citations
  2. 2Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells2008 · 305 citations
  3. 3Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer2023 · 355 citations